Artal Group S.A. Prothena Corp Public LTD CO Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
A detailed history of Artal Group S.A. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Artal Group S.A. holds 1,001,360 shares of PRTA stock, worth $18.1 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
1,001,360
Previous 1,001,360
-0.0%
Holding current value
$18.1 Million
Previous $24.8 Million
16.67%
% of portfolio
1.31%
Previous 1.34%
Shares
7 transactions
Others Institutions Holding PRTA
# of Institutions
180Shares Held
42.8MCall Options Held
77.7KPut Options Held
92.7K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$210 Million8.45% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.24MShares$76.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$69.8 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.64MShares$65.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.93MShares$35 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $849M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...